Related Party Transactions

12 Months Ended

Mar. 31, 2020

In the year ended March 31, 2020, we have incurred expenses on behalf of John C. Malone, a former director of the Company, for reimbursement of certain litigation costs of approximately $1.6 million (2019 - $2.4 million; 2018 - $4.4 million), which are included in restructuring and other in the consolidated statements of operations.

In the year ended March 31, 2020, we have incurred expenses on behalf of Mark H. Rachesky, the Chairman of the Board of the Company and principal of MHR Fund Management, for reimbursement of certain litigation costs of less than $0.1 million (2019 - $0.8 million; 2018 - $1.2 million), which are included in restructuring and other in the consolidated statements of operations. MHR Fund Management holds approximately 23% of the Company’s outstanding Class A voting shares and 11% of the Company's outstanding Class B non-voting common stock as of May 18, 2020.

During the year ended March 31, 2018, the Company participated in an equity offering of its equity method investee, Atom Tickets, and subscribed for an additional $10.0 million in equity interests. Gordon Crawford, a director of the Company, is a director of and an investor in Atom Tickets.

In April 2008, Lions Gate Films, Inc., a wholly-owned subsidiary of the Company (“LGF”), entered into a sales agency agreement (as amended) with Shrink, LLC for distribution rights to the film Shrink. Michael Burns, the Vice Chairman and a director of the Company, owns a 100% interest in Shrink, LLC. During the year ended March 31, 2020, no amounts were paid to Shrink, LLC under this agreement (2019 - less than $0.1 million, 2018 - $0.1 million).

Transactions with Equity Method Investees

In the ordinary course of business, we are involved in related party transactions with equity method investees. These related party transactions primarily relate to the licensing and distribution of the Company's films and television programs, for which the impact on the Company's consolidated balance sheets and consolidated statements of operations is as follows (see Note 1 and Note 5):



	March 31,
	2020			2019
	(Amounts in millions)
Consolidated Balance Sheets
Accounts receivable	$	2.5		$	2.2
Other assets, noncurrent⁽¹⁾	3.3			7.3
Total due from related parties	$	5.8		$	9.5

Participations and residuals, current	12.3			9.5
Participations and residuals, noncurrent	1.4			8.2
Total due to related parties	$	13.7		$	17.7

	Year Ended March 31,
	2020			2019		2018
	(Amounts in millions)
Consolidated Statements of Operations
Revenues	$	4.6		$	4.7	$	8.9
Direct operating expense	$	13.8		$	32.2	$	22.0
Distribution and marketing expense	$	—		$	3.0	$	3.5
General and administrative expense⁽²⁾	$	(1.1	)	$	0.7	$	(3.7	)
Interest and other income	$	1.7		$	0.4	$	—

__________________________________


(1)	During the years ended March 31, 2020 and 2019, the Company made loans of $12.5 million and $20.7 million, respectively, to certain of its equity method investees, of which $3.3 million and $7.3 million, respectively, are included in other assets, noncurrent in the Company's consolidated balance sheets (net of equity interests losses applied against such loans), and included in the table above.

(2)Amounts primarily represent reimbursement for certain shared services for equity method investees.

In addition, as of March 31, 2020, the Company has entered into a lease that has not yet commenced related to a studio facility owned by an equity-method investee, for which construction has not yet been completed. See Note 8 for further information.